Moffitt Cancer Center [clinicaltrials_resource:e4b60b0275e81f4bd5cbb991299f9515]
Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms [clinicaltrials:NCT00082784]clinicaltrials:NCT00096200clinicaltrials:NCT00126490Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase [clinicaltrials:NCT00383474]clinicaltrials:NCT00392782Phase 1/2 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma [clinicaltrials:NCT00461045]AZD6244 in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine [clinicaltrials:NCT00559949]Bortezomib and Vorinostat in Treating Patients With Recurrent Mantle Cell Lymphoma or Recurrent and/or Refractory Diffuse Large B-Cell Lymphoma [clinicaltrials:NCT00703664]Support for People Undergoing Chemotherapy [clinicaltrials:NCT00740038]A Study of ARRY-614 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome [clinicaltrials:NCT00916227]AZD6244 (Selumetinib) in Treating Patients With Multiple Myeloma [clinicaltrials:NCT01085214]Evaluate Safety/Tolerability Intra-Arterial Temozolomide in Patients w/Extremity Melanoma by Isolated Limb Infusion [clinicaltrials:NCT01127594]clinicaltrials:NCT01149356clinicaltrials:NCT01361464clinicaltrials:NCT01488487A Study of ARRY-614 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes [clinicaltrials:NCT01496495]Brentuximab Vedotin Plus AVD in Limited-stage Hodgkin Lymphoma [clinicaltrials:NCT01534078]Phase 1 Study of MLN0264 in Adult Patients With Advanced Gastrointestinal Malignancies Expressing Guanylyl Cyclase C [clinicaltrials:NCT01577758]Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced or Metastatic Solid Tumor Cancer [clinicaltrials:NCT01607905]Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer [clinicaltrials:NCT01638546]clinicaltrials:NCT02097225
location [clinicaltrials_vocabulary:location]
Moffitt Cancer Center [clinicaltrials_resource:e4b60b0275e81f4bd5cbb991299f9515]
Bio2RDF identifier
e4b60b0275e81f4bd5cbb991299f9515
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:e4b60b0275e81f4bd5cbb991299f9515
address [clinicaltrials_vocabulary:address]
identifier
clinicaltrials_resource:e4b60b0275e81f4bd5cbb991299f9515
title
Moffitt Cancer Center
@en
type
label
Moffitt Cancer Center [clinicaltrials_resource:e4b60b0275e81f4bd5cbb991299f9515]
@en